Your session is about to expire
← Back to Search
Vitamin Supplement
Vitamin D supplementation for Respiratory Infection
N/A
Waitlist Available
Research Sponsored by The Cooper Health System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 9 months
Awards & highlights
Study Summary
This trial is looking at whether taking vitamin D3 every day can help prevent respiratory infections in hospital workers.
Eligible Conditions
- Respiratory Infection
- Coronavirus
- Flu
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 9 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~9 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Influenza-like illness
Side effects data
From 2013 Phase 3 trial • 122 Patients • NCT014735897%
Nasopharyngitis
6%
Prostatitis
5%
Constipation
5%
Osteoporosis
5%
Insomnia
5%
Arthralgia
5%
Back pain
3%
Asthenia
3%
Nausea
3%
Hypoaesthesia
3%
Myalgia
2%
Cellulitis
2%
Thirst
2%
Presyncope
2%
Chondropathy
2%
Palpitations
2%
Subdural haematoma
2%
Fall
2%
Dacryostenosis acquired
2%
Abdominal pain lower
2%
Dental caries
2%
Diarrhoea
2%
Diverticulum intestinal
2%
Faecaloma
2%
Gastritis atrophic
2%
Oedema peripheral
2%
Pain
2%
Pyrexia
2%
Ear infection
2%
Oral candidiasis
2%
Wound infection
2%
Contusion
2%
Humerus fracture
2%
Laceration
2%
Blood alkaline phosphatase increased
2%
Hyperlipidaemia
2%
Pain in extremity
2%
Spinal column stenosis
2%
Trigger finger
2%
Dizziness
2%
Headache
2%
Mental status changes
2%
Urinary retention
2%
Dyshidrotic eczema
2%
Hypertrophic scar
2%
Rash
2%
Thrombosis
2%
Arrhythmia
2%
Gastrooesophageal reflux disease
2%
Hiatus hernia
2%
Respiratory failure
2%
Decreased appetite
2%
Pneumonia
2%
Oral herpes
2%
Bradyarrhythmia
2%
Supraventricular tachycardia
2%
Vertigo
2%
Cholelithiasis
2%
Hypoglycaemia
2%
Musculoskeletal pain
2%
Osteoarthritis
2%
Neuralgia
2%
Paraesthesia
2%
Parkinson's disease
100%
80%
60%
40%
20%
0%
Study treatment Arm
Placebo
Teriparatide
Placebo Follow-up
Teriparatide Follow-up
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Group II: ControlActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Vitamin D supplementation
2022
Completed Phase 4
~2250
Find a Location
Who is running the clinical trial?
The Won Sook Chung FoundationUNKNOWN
Won Sook Chung FoundationUNKNOWN
1 Previous Clinical Trials
9,000 Total Patients Enrolled
The Cooper Health SystemLead Sponsor
76 Previous Clinical Trials
32,236 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Your doctor believes that you may not live for more than one month.You have had problems taking vitamin D3 supplements in the past.You take more than 5000 IU of vitamin D every day.You are currently using calcipotriene.You are currently taking digoxin.You are allergic to wool.You have a medical condition that affects how your body processes vitamin D.You have a history of kidney stones.You are taking aluminum-containing phosphate binders for kidney problems.
Research Study Groups:
This trial has the following groups:- Group 1: Intervention
- Group 2: Control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is there still an opportunity to apply for this research endeavor?
"As indicated by clinicaltrials.gov, this study is not currently recruiting patients; the trial was posted on October 27th 2020 and its information last updated on November 28th 2022. Fortunately, 1671 other trials are actively searching for participants at this time."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger